Trials are run out of state of the art cancer centres/universities like city of hope and managed by expert scientists, His Companies are run by industry respected CEOs. Spreading himself thin? Do you think PH is on the end of the bed doing transfusions. PH is a licensing/talent head hunter and will jump on a licensing opportunity when they arise but only when he has multiple assets for the pipeline and an A1 team he lures in from the best of big pharma. The ignore list is growing.
CHM Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)